Diagnostics Channel NavClinical Channel NavInformatics Channel NavCancer Channel NavRegister Nav
MMTC15_Header  
MMTC M Header 

Dinner Short Course

Building an Investigational Program to Establish the Clinical Value of a Test  


Sunday, February 9, 2014 | 2:30 - 5:30 pm | Moscone North Convention Center | San Fransisco, CA 


Building an Investigational Program to Establish the Clinical Value of a Test   

Instructors: 

Catherine SchnabelCatherine Schnabel, Ph.D., Vice President, Medical, Clinical & Regulatory Affairs, bioTheranostics, Inc. 

 

 

 

 

 

 

Brock SchroederBrock Schroeder, Ph.D., Director, Medical & Scientific Affairs, bioTheranostics Inc. 

 

 

 

 

 

 

Development of a strong clinical program for diagnostic tests requires consideration and integration of key strategic drivers such as clinical adoption, reimbursement, & regulatory filing based on a proposed indication for use.  In considering the appropriate use of new tests, clinicians and health care policymakers must consider the accuracy with which a test identifies a patient’s clinical status (clinical validity), the risks and benefits resulting from test use (clinical utility), and the medical value of the test (health economics/outcomes). This workshop will provide a basic framework for establishing comprehensive clinical evidence based on analytical validity, clinical validity, clinical utility, and health economics and effectiveness, and utilize a case study of the 92-gene assay, CancerTYPE ID to build these points.

  • Clinical study designs for biomarker research/Levels of evidence
  • Formulating clinical endpoints
  • Framework for clinical evidence
  • Data requirements for various stakeholders
  • Case study

 

 

Back To Short Courses 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 



2014 Premier Sponsors:

 Elsevier   

 

NanoString 

 

Quanterix 

 

RemedyMD 

 

Singulex 

 

Thomson Reuters